FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced Boyd Clarke, Executive Chairman is scheduled to present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12 at 4:30 PM E.T.

The Presentation will be webcast live and can be accessed by visiting the ‘Investors’ page of the Company’s website: http://flugen.com/for-investors/. The webcast will be archived on the Company’s website for 30 days following the presentation.

Click here to read the full article.